Loading...
Loading...
By David Kersenobich - Tue, 08/22/2023 - 14:00
Individuals are about 99.8% identical in terms of human genome but 80-90% different in their individual gut microbioma, writes David Kershenobich.
Featured content
Thu, 04/11/2024 - 15:25
Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.
https://mexicobusiness.news/tag/david-kershenobich
More Health
By David Kersenobich - Tue, 05/16/2023 - 10:00
Amid the 5th industrial revolution connecting man, machine and AI, we can only be astonished by the liver’s efficiency, writes David Kershenobich.
By David Kersenobich - Wed, 01/11/2023 - 10:00
Innovation is having a major impact on the construction of the doctor-patient relationship. But it doesn’t stop there, writes David Kershenobich.
By Miriam Bello - Mon, 09/05/2022 - 11:45
Investment in innovative diagnosis is necessary to combat the large burden of chronic diseases in Mexico, agree experts.
By Miriam Bello - Fri, 07/15/2022 - 10:33
Innovation has been essential to INCMNSZ, allowing the institute to develop a ventilator to treat COVID-19 patients, says David Kershenobich.
By Miriam Bello - Tue, 06/07/2022 - 10:54
Recognized national healthcare entities join forces to develop innovative therapies to treat leukemia and lymphoma.
By Miriam Bello - Thu, 10/28/2021 - 13:18
A network of patient associations presented several petitions to the Chamber of Deputies searching to improve care for non-communicable diseases.
By Miriam Bello - Wed, 07/28/2021 - 18:51
Medical devices have a large role to play in VBHC models but there is still a market transition in progress.
By David Kersenobich - Wed, 06/02/2021 - 09:12
NCDs are among the main causes of morbidity and mortality in Mexico. David Kersenobich discusses why a change in care model is needed.
By Miriam Bello - Thu, 05/06/2021 - 15:51
Private health coverage could be boosted through inclusive financial services. How can these improve in Mexico?
